EpiBiome is a venture-backed precision microbiome engineering company tackling the challenge of antibiotic resistance by developing alternatives to small-molecule antibiotics for use in healthcare, veterinary and agriculture industries.
The microbiome is implicated in a number of metabolic pathways and communicates closely with our body in health and diseases. Imbalance of microflora is linked to obesity, diabetes, allergies, cancer, and even depression and autism. However, these facts have been ignored for decades. But today, the microbiome market is catching …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.